Background illustration for clinical trials search

Paid Clinical Trials ​Thousand Oaks

Discover 3,049 paid clinical trials in ​Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Project SOAR (Speaking Our African American Realities) Awakenings for Black American Women Diagnosed With Breast Cancer

for
Breast Cancer
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: Female

Age: 18+

Code: NCT07208084

Recruiting

Does Bladder Instillation Reduce Time to Discharge After Sling Surgery

for
Stress Urinary Incontinence
Location: Beverly Hills CA
Sponsor: Cedars-Sinai Medical Center

Sex: Female

Age: 18+

Code: NCT02277288

Recruiting

Phase 3 Efficacy and Safety Study of VVZ-149 Injections for Postoperative Pain Following Bunionectomy

for
Pain, Postoperative
Location: Anaheim CA, Phoenix AZ, San Antonio TX
Sponsor: Vivozon, Inc.

Sex: All

Age: 18+

Code: NCT04430088

Phase 3, Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Melanoma, Head and Neck Cancer,
Location: Duarte CA, Vancouver, Edmonton, Houston TX,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06172478

Phase 2, Recruiting

PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)

for
Rheumatoid Arthritis
Location: Whittier CA
Sponsor: Scipher Medicine

Sex: All

Age: 18 - 70+

Code: NCT06390709

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

for
HIV
Location: Los Angeles CA, Providence RI
Sponsor: Westat

Sex: All

Age: 16 - 24

Code: NCT06444360

Recruiting

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

for
Acute Myeloid Leukemia (AML)
Location: Los Angeles CA, Orange CA, La Jolla CA, Clovis CA,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07007312

Phase 3, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Cancer, PDAC,
Location: Los Angeles CA, La Jolla CA, Las Vegas NV, Palo Alto CA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07252232

Phase 3, Recruiting

Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

for
Recessive Dystrophic Epidermolysis Bullosa
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 7+

Code: NCT03392909

Phase 1, Phase 2, Recruiting

Coaching and Leadership in Autism Support Settings

for
Autism Spectrum Disorder (ASD)
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 5+

Code: NCT07276750

Recruiting

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

for
Bladder Carcinoma, Genitourinary System Neoplasm,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05519878

Recruiting

A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

for
Platinum-resistant Ovarian Cancer
Location: El Segundo CA, Newport Beach CA
Sponsor: ImmunityBio, Inc.

Sex: Female

Age: 18 - 70+

Code: NCT06710288

Phase 2, Recruiting

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

for
Squamous Cell Carcinoma of Head and Neck
Location: Los Angeles CA, Murrieta CA, Fullerton CA, La Jolla CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07276399

Phase 3, Recruiting

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV),
Location: Beverly Hills CA, Los Angeles CA, Fullerton CA,
Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT06308978

Phase 1, Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Los Angeles CA, Orange CA, Scottsdale AZ, Gilbert AZ,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT07188558

Phase 3, Recruiting

Automated Insulin for Management of Intrapartum Glycemia

for
Type 1 Diabetes (T1D), Pregnancy, Pre-Gestational Diabetes
Location: Los Angeles CA, San Diego CA, San Francisco CA
Sponsor: University of California, San Francisco

Sex: Female

Age: 18 - 55

Code: NCT06883344

Recruiting

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Burbank CA, Reno NV, Phoenix AZ, Grand Junction CO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06170788

Phase 3, Recruiting

Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms

for
T-Cell Neoplasm, Lymphoproliferative Disorders
Location: Duarte CA, Ann Arbor MI, Columbus OH, Durham NC
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT04858256

Phase 2, Recruiting

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

for
Hypogammaglobulinemia, Bacterial Infections,
Location: Huntington Park CA, Bullhead City AZ, Canton OH,
Sponsor: Grifols Therapeutics LLC

Sex: All

Age: 18+

Code: NCT05645107

Phase 3, Recruiting

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort

for
Duchenne Muscular Dystrophy
Location: Los Angeles CA, La Jolla CA, Palo Alto CA,
Sponsor: Sarepta Therapeutics, Inc.

Sex: Male

Age: 2+

Code: NCT04626674

Phase 1, Recruiting